CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
Human T cell lymphotropic virus-1 (HTLV-1) primarily infects CD4+ T cells, causing inflammatory disorders or a T cell malignancy in 5% to 10% of carriers. The cytotoxic T lymphocyte (CTL) response is a key factor that controls the viral load and thus the risk of disease. The ability to detect the vi...
| Published in: | PLoS Pathogens |
|---|---|
| Main Authors: | Kiruthika Manivannan, Aileen G Rowan, Yuetsu Tanaka, Graham P Taylor, Charles R M Bangham |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-04-01
|
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1005560&type=printable |
Similar Items
Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
by: De Zeng, et al.
Published: (2016-01-01)
by: De Zeng, et al.
Published: (2016-01-01)
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
by: Rajeshree Pujari, et al.
Published: (2015-03-01)
by: Rajeshree Pujari, et al.
Published: (2015-03-01)
HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy
by: Allison K. Maher, et al.
Published: (2024-01-01)
by: Allison K. Maher, et al.
Published: (2024-01-01)
Dynamics and consequences of the HTLV-1 proviral plus-strand burst.
by: Saumya Ramanayake, et al.
Published: (2022-11-01)
by: Saumya Ramanayake, et al.
Published: (2022-11-01)
Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection.
by: Anat Melamed, et al.
Published: (2013-03-01)
by: Anat Melamed, et al.
Published: (2013-03-01)
Time-course of host cell transcription during the HTLV-1 transcriptional burst.
by: Helen Kiik, et al.
Published: (2022-05-01)
by: Helen Kiik, et al.
Published: (2022-05-01)
HLA class I binding of HBZ determines outcome in HTLV-1 infection.
by: Aidan Macnamara, et al.
Published: (2010-09-01)
by: Aidan Macnamara, et al.
Published: (2010-09-01)
The HTLV-1 Virological Synapse
by: Mohamed Nejmeddine, et al.
Published: (2010-07-01)
by: Mohamed Nejmeddine, et al.
Published: (2010-07-01)
Anti-HTLV-1/2 IgG Antibodies in the Breastmilk of Seropositive Mothers
by: Carolina Rosadas, et al.
Published: (2021-06-01)
by: Carolina Rosadas, et al.
Published: (2021-06-01)
Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
by: Antonio Mastino, et al.
Published: (2011-05-01)
by: Antonio Mastino, et al.
Published: (2011-05-01)
An HTLV-1-Infected Humanized Mouse Model Expressing HLA-A*02:01 Demonstrates Effective CTL-Mediated Suppression of HTLV-1
by: Shinsuke Nakajima, et al.
Published: (2025-09-01)
by: Shinsuke Nakajima, et al.
Published: (2025-09-01)
The Relationship between the TSLC1 Silencing and DNA Methylation in Human Lung Cancer Cells
by: Tieying SUN, et al.
Published: (2010-05-01)
by: Tieying SUN, et al.
Published: (2010-05-01)
Comparative Investigation of TSLC1 Tumor Suppressor Protein Expression in Cancerous and Normal Ovarian Specimens
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2013-09-01)
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2013-09-01)
Prognostic role and tumor-suppressive effects of CADM family members and the potential molecular mechanisms of CADM1 in neuroblastoma
by: Yu Wang, et al.
Published: (2025-05-01)
by: Yu Wang, et al.
Published: (2025-05-01)
The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.
by: Aris E N Aristodemou, et al.
Published: (2023-07-01)
by: Aris E N Aristodemou, et al.
Published: (2023-07-01)
Clonality of HTLV-2 in natural infection.
by: Anat Melamed, et al.
Published: (2014-03-01)
by: Anat Melamed, et al.
Published: (2014-03-01)
Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan
by: Mariko Mizuguchi, et al.
Published: (2020-01-01)
by: Mariko Mizuguchi, et al.
Published: (2020-01-01)
Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
by: Larissa Deadame de Figueiredo Nicolete, et al.
Published: (2012-09-01)
by: Larissa Deadame de Figueiredo Nicolete, et al.
Published: (2012-09-01)
High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London Experience
by: Graham P. Taylor, et al.
Published: (2024-07-01)
by: Graham P. Taylor, et al.
Published: (2024-07-01)
Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity.
by: Farhoud Faraji, et al.
Published: (2012-09-01)
by: Farhoud Faraji, et al.
Published: (2012-09-01)
Quantification of HTLV-1 clonality and TCR diversity.
by: Daniel J Laydon, et al.
Published: (2014-06-01)
by: Daniel J Laydon, et al.
Published: (2014-06-01)
Global dynamics of a HTLV-I infection model with CTL response
by: Xinguo Sun, et al.
Published: (2013-07-01)
by: Xinguo Sun, et al.
Published: (2013-07-01)
HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients’ T-cells
by: Annika P. Schnell, et al.
Published: (2022-08-01)
by: Annika P. Schnell, et al.
Published: (2022-08-01)
HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil.
by: David Nunes, et al.
Published: (2017-01-01)
by: David Nunes, et al.
Published: (2017-01-01)
Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.
by: Sonja Tattermusch, et al.
Published: (2012-01-01)
by: Sonja Tattermusch, et al.
Published: (2012-01-01)
HTLV-1 Infection and Cervicovaginal Susceptibility to High-Risk HPV: Findings from Women Living with HTLV-1 in Salvador, Brazil
by: Alisson de Aquino Firmino, et al.
Published: (2025-01-01)
by: Alisson de Aquino Firmino, et al.
Published: (2025-01-01)
The clinical utility of HTLV-1 viral load measurement
by: Hilburn Silva, et al.
Published: (2011-06-01)
by: Hilburn Silva, et al.
Published: (2011-06-01)
The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis
by: Anat Melamed, et al.
Published: (2018-06-01)
by: Anat Melamed, et al.
Published: (2018-06-01)
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
by: Gergès Rizkallah, et al.
Published: (2017-04-01)
by: Gergès Rizkallah, et al.
Published: (2017-04-01)
Elucidation of the Mechanism of Host NMD Suppression by HTLV-1 Rex: Dissection of Rex to Identify the NMD Inhibitory Domain
by: Kazumi Nakano, et al.
Published: (2022-02-01)
by: Kazumi Nakano, et al.
Published: (2022-02-01)
Necl-1/CADM3 regulates cone synapse formation in the mouse retina
by: Rumi Kawashima, et al.
Published: (2024-04-01)
by: Rumi Kawashima, et al.
Published: (2024-04-01)
Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma
by: Jiani Nie, et al.
Published: (2023-04-01)
by: Jiani Nie, et al.
Published: (2023-04-01)
HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
by: Daniel Bradshaw, et al.
Published: (2022-04-01)
by: Daniel Bradshaw, et al.
Published: (2022-04-01)
Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection
by: Abelardo Q.-C. Araujo
Published: (2020-03-01)
by: Abelardo Q.-C. Araujo
Published: (2020-03-01)
Stability analysis of general delayed HTLV-I dynamics model with mitosis and CTL immunity
by: A. M. Elaiw, et al.
Published: (2022-08-01)
by: A. M. Elaiw, et al.
Published: (2022-08-01)
Detection of CADM1, MAL, and PAX1 Methylation by ddPCR for Triage of HPV-Positive Cervical Lesions
by: Maria Anisimova, et al.
Published: (2025-06-01)
by: Maria Anisimova, et al.
Published: (2025-06-01)
Cell Adhesion Molecule 1 (CADM1) Is an Independent Prognostic Factor in Patients with Cutaneous Squamous Cell Carcinoma
by: Natsuko Saito-Sasaki, et al.
Published: (2021-05-01)
by: Natsuko Saito-Sasaki, et al.
Published: (2021-05-01)
HTLV-1 Disease
by: Chloé Journo, et al.
Published: (2021-08-01)
by: Chloé Journo, et al.
Published: (2021-08-01)
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications.
by: Lishomwa C Ndhlovu, et al.
Published: (2011-04-01)
by: Lishomwa C Ndhlovu, et al.
Published: (2011-04-01)
Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
by: Galvao-Castro Bernardo, et al.
Published: (2011-06-01)
by: Galvao-Castro Bernardo, et al.
Published: (2011-06-01)
Similar Items
-
Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
by: De Zeng, et al.
Published: (2016-01-01) -
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
by: Rajeshree Pujari, et al.
Published: (2015-03-01) -
HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy
by: Allison K. Maher, et al.
Published: (2024-01-01) -
Dynamics and consequences of the HTLV-1 proviral plus-strand burst.
by: Saumya Ramanayake, et al.
Published: (2022-11-01) -
Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection.
by: Anat Melamed, et al.
Published: (2013-03-01)
